- Home
- CMPX vs SCPH Comparison
CMPX vs SCPH Comparison
Compare CMPX & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- SCPH
- Stock Information
- Founded
- CMPX 2014
- SCPH 2013
- Country
- CMPX United States
- SCPH United States
- Employees
- CMPX N/A
- SCPH N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- CMPX Health Care
- SCPH Health Care
- Exchange
- CMPX Nasdaq
- SCPH Nasdaq
- Market Cap
- CMPX 217.4M
- SCPH 163.3M
- IPO Year
- CMPX N/A
- SCPH 2017
- Fundamental
- Price
- CMPX $1.58
- SCPH $5.00
- Analyst Decision
- CMPX Strong Buy
- SCPH Strong Buy
- Analyst Count
- CMPX 2
- SCPH 2
- Target Price
- CMPX $9.00
- SCPH $19.00
- AVG Volume (30 Days)
- CMPX 401.2K
- SCPH 289.6K
- Earning Date
- CMPX 08-12-2024
- SCPH 08-14-2024
- Dividend Yield
- CMPX N/A
- SCPH N/A
- EPS Growth
- CMPX N/A
- SCPH N/A
- EPS
- CMPX N/A
- SCPH N/A
- Revenue
- CMPX $850,000.00
- SCPH $24,048,000.00
- Revenue This Year
- CMPX N/A
- SCPH $195.62
- Revenue Next Year
- CMPX $950.68
- SCPH $145.07
- P/E Ratio
- CMPX N/A
- SCPH N/A
- Revenue Growth
- CMPX N/A
- SCPH 549.77
- 52 Week Low
- CMPX $0.77
- SCPH $3.24
- 52 Week High
- CMPX $2.34
- SCPH $7.68
- Technical
- Relative Strength Index (RSI)
- CMPX 65.76
- SCPH 51.01
- Support Level
- CMPX $1.42
- SCPH $4.86
- Resistance Level
- CMPX $1.61
- SCPH $5.30
- Average True Range (ATR)
- CMPX 0.12
- SCPH 0.28
- MACD
- CMPX 0.02
- SCPH -0.03
- Stochastic Oscillator
- CMPX 66.56
- SCPH 21.87
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.